The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model
Abstract
De novo loss‐of‐function mutations in methyl‐CpG‐binding protein 2 (MeCP2) lead to the neurodevelopmental disorder Rett syndrome (RTT). Despite promising results from strategies aimed at increasing MeCP2 levels, additional studies exploring how hypomorphic MeCP2 mutations impact the therapeutic window are needed. Here, we investigated the consequences of genetically introducing a wild‐type MECP2 transgene in the Mecp2 R133C mouse model of RTT. The MECP2 transgene reversed the majority of RTT‐like phenotypes exhibited by male and female Mecp2 R133C mice. However, three core symptom domains were adversely affected in female Mecp2R133C/+ animals; these phenotypes resemble those observed in disease contexts of excess MeCP2. Parallel control experiments in Mecp2Null/+ mice linked these adverse effects to the hypomorphic R133C mutation. Collectively, these data provide evidence regarding the safety and efficacy of genetically overexpressing functional MeCP2 in Mecp2 R133C mice and suggest that personalized approaches may warrant consideration for the clinical assessment of MeCP2‐targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have also reported that genetic models demonstrated predictive validity, with insight into the development of therapeutic approaches to the prevention and treatment of ASD [97,98].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [98]
In the citing paper
“Many mutant mouse and rat models have been developed with relatively high face validity for the behavioral signs associated with Rett Syndrome [99,101,103,148,149], construct validity for morphological and functional changes in brain neuronal functions, and even predictive validity for using pharmacological agents and for wild-type protein gene therapy that rescue neuronal functions [97,98].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230 · cited 1×
“Seminal findings in preclinical hemizygous Mecp2 null models have described that RTT symptoms are reversible if MeCP2 levels are restored to those of wild-type mice, even after disease onset.(2,3) Several studies have since shown that viral delivery of human MECP2 in hemizygous and heterozygous Mecp2 null mice can ach…”
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., David Sweatt, J., & Zoghbi, H. Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh282 · Cited by 626
Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome
Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Teague, R., Antalffy, B., Armstrong, D., Arancio, O., Sweatt, J. D., & Zoghbi, H. Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2623-05.2006 · Cited by 545
Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome
Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O., Zoghbi, H., Percy, A., & Glaze, D. G. (2008) · Neurology · doi:10.1212/01.wnl.0000291011.54508.aa · Cited by 498 · cited 2×
“The R133C mutation is one of most common mutations in patients but it also leads to a mild presentation of the disease, similar to R306C.(19,21,29) Here, we behaviorally validated the Mecp2 R133C”
Cuddapah, V. A., Pillai, R. B., Shekar, K. V., Lane, J. B., Motil, K. J., Skinner, S. A., Tarquinio, D. C., Glaze, D. G., McGwin, G., Kaufmann, W. E., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102113 · Cited by 311 · cited 3×
“19,21,29 Here, we behaviorally validated the Mecp2 R133C mice as a hypomorphic mutant mouse model of RTT. 47 This further supports the clinical observation that the R133C mutation is not a functional null allele, but rather is hypo-morphic and conveys a milder phenotype.”
Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome
Robinson, L., Guy, J., McKay, L., Brockett, E., Spike, R. C., Selfridge, J., De Sousa, D., Merusi, C., Riedel, G., Bird, A., et al. (2012) · Brain · doi:10.1093/brain/aws096 · Cited by 157
Radically truncated MeCP2 rescues Rett syndrome-like neurological defects
Tillotson, R., Selfridge, J., Koerner, M. V., Gadalla, K. K. E., Guy, J., De Sousa, D., Hector, R. D., Cobb, S. R., & Bird, A. (2017) · Nature · doi:10.1038/nature24058 · Cited by 155
Kron, M., Howell, C. J., Adams, I. T., Ransbottom, M., Christian, D., Ogier, M., & Katz, D. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2159-12.2012 · Cited by 154 · cited 1×
“The lack of abnormal PPI contrasted from previous findings, wherein enhanced PPI was observed in Mecp2 heterozygous females, Mecp2 mice, and glutamatergic- or GABAergic-specific Mecp2 knockout mice.(50,36,48,51) However, compared to these studies, which utilized older mice of different background strains, we evaluated…”
Research works printed but not linked: 43
- 10.1038/13810 · DOI · Paper page
- 10.1073/pnas.0401626101 · DOI · Paper page
- 10.1038/mt.2012.200 · DOI · Paper page
- 10.1016/j.omtm.2017.04.006 · DOI
- 10.1016/j.omtm.2017.04.007 · DOI
- Powers S, 2019, Rett syndrome gene therapy improves survival and ameliorates behavioral phenotypes in MeCP2 null (S51.002), Neurology, 92
- 10.1523/JNEUROSCI.1854-13.2013 · DOI · Paper page
- 10.1523/JNEUROSCI.6000-11.2012 · DOI
- 10.1038/nrg2987 · DOI · Paper page
- 10.1002/ajmg.b.32534 · DOI
- 10.1086/302105 · DOI · Paper page
- 10.1038/sj.ejhg.5201682 · DOI · Paper page
- 10.1016/j.brainres.2019.146644 · DOI
- 10.1086/382228 · DOI
- 10.1093/hmg/ddh142 · DOI
- 10.1016/j.rasd.2010.06.007 · DOI
- 10.1093/hmg/ddv496 · DOI
- 10.7554/eLife.02676 · DOI
- 10.1093/hmg/ddaa102 · DOI
- 10.1007/s00439-008-0585-6 · DOI
- 10.1172/JCI90967 · DOI
- 10.1093/hmg/ddv030 · DOI
- 10.1177/08830738030180100301 · DOI
- 10.1136/jmg.40.5.e52 · DOI
- 10.1212/01.wnl.0000304752.50773.ec · DOI · Paper page
- 10.1074/jbc.M803021200 · DOI
- 10.1016/j.neuron.2016.08.017 · DOI
- 10.1021/acschemneuro.7b00414 · DOI
- 10.1093/hmg/dds208 · DOI
- 10.4172/2165-7890.S1-005 · DOI · Paper page
- 10.1093/hmg/ddw074 · DOI
- 10.1126/scitranslmed.aai7459 · DOI
- 10.1016/j.resp.2013.06.022 · DOI
- 10.1155/2015/746157 · DOI
- 10.1016/j.neuroscience.2007.02.009 · DOI · Paper page
- 10.1093/hmg/dds406 · DOI · Paper page
- 10.1111/j.1601-183X.2006.00258.x · DOI · Paper page
- 10.1016/j.nbd.2020.105235 · DOI
- 10.1124/jpet.117.246991 · DOI
- 10.1093/brain/awl022 · DOI · Paper page
- 10.1093/hmg/ddn062 · DOI · Paper page
- 10.1093/hmg/ddn061 · DOI
- 10.7554/eLife.14199 · DOI
Cited by
Ornoy, A., Echefu, B., & Becker, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910469 · Cited by 41
Metadata
- Authors
- Vermudez, S. A. D., Gogliotti, R. G., Arthur, B., Buch, A., Morales, C., Moxley, Y., Rajpal, H., Conn, P. J., & Niswender, C. M.
- Affiliations
- Department of Pharmacology and Warren Center for Neuroscience Drug Discovery Vanderbilt University Nashville Tennessee USA
- Department of Molecular Pharmacology and Neuroscience Loyola University Chicago Chicago Illinois USA
- Venue
- Genes, Brain and Behavior
- Publisher
- Wiley
- Published
- 2021-05-28
- Volume
- 21
- Issue
- 1
- ISSN
- 1601-1848
- 1601-183X
- Cited by
- 12
- References
- 9
- Language
- en
- Funders
- National Institute of Mental Health (F31MH119699, K01MH112983)
- National Institute of Neurological Disorders and Stroke (R01NS112171)
- National Institutes of Health (T32 GM007628)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.